Next Article in Journal
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097–6110
Previous Article in Journal
Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors
 
 
Article

Article Versions Notes

Curr. Oncol. 2024, 31(11), 7165-7176; https://doi.org/10.3390/curroncol31110528
Action Date Notes Link
article xml file uploaded 15 November 2024 05:51 CET Original file -
article xml uploaded. 15 November 2024 05:51 CET Update https://www.mdpi.com/1718-7729/31/11/528/xml
article pdf uploaded. 15 November 2024 05:51 CET Version of Record https://www.mdpi.com/1718-7729/31/11/528/pdf
article html file updated 15 November 2024 05:54 CET Original file https://www.mdpi.com/1718-7729/31/11/528/html
Back to TopTop